Total Return chart IRLAB Therapeutics AB

Stocks

Market Closed - Nasdaq Stockholm 17:00:00 31/08/2026 BST			5-day change	1st Jan Change
1.792 ^SEK	+0.22%		+3.34%	-9.04%

08-28	Redeye sets a justified value of 6.60 kronor for Irlab, partnerships remain in focus	FW
08-26	IRLAB Therapeutics AB Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026	CI

"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.